HOOKIPA Pharma Inc. (HOOK): Nasdaq/NYSE listing notice — HOOKIPA Pharma receives Nasdaq non-compliance notice for bid price below $1.00

HOOKIPA Pharma Inc.

Nasdaq letter on Jan 17, 2023: bid price below $1.00 for 30 consecutive business days.
180-day cure period until July 17, 2023 to regain compliance by closing at $1.00 for 10 days.
Company evaluating options including reverse stock split authorized at June 2022 meeting.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

HOOKIPA Pharma Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

January 17, 2023, HOOKIPA Pharma Inc. (the “Company”) received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the closing bid price of the Company’s common stock was below $1.00 per share for 30 consecutive business days, and that, therefore, the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), which is the minimum bid price requirement for continued listing on the Nasdaq Global Select Market. The notice from Nasdaq has no immediate effect on the listing of the Company’s common stock, and the common stock will continue to be listed on the Nasdaq Global Se

View on SEC.gov

Browse all listing & compliance notices →

HOOKIPA Pharma Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-005397

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.